Deutsche Bank
CMPX icon

Deutsche Bank’s Compass Therapeutics CMPX Stock Holding History

Deutsche Bank’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$294K Buy
134,350
+998
+0.7% +$2.95K ﹤0.01% 3046
2026
Q1 		$705K Buy
133,352
+24,079
+22% +$139K ﹤0.01% 2387
2025
Q4 		$587K Buy
109,273
+13,488
+14% +$62.3K ﹤0.01% 2486
2025
Q3 		$335K Buy
95,785
+11,888
+14% +$37.5K ﹤0.01% 2773
2025
Q2 		$218K Sell
83,897
-18,144
-18% -$37.4K ﹤0.01% 2917
2025
Q1 		$194K Buy
+102,041
New +$271K ﹤0.01% 2960
2024
Q4 		– Sell
-86,164
Closed -$159K – 3626
2024
Q3 		$159K Hold
86,164
– – ﹤0.01% 3028
2024
Q2 		$86.2K Buy
86,164
+43,476
+102% +$63.5K ﹤0.01% 3162
2024
Q1 		$84.5K Sell
42,688
-1,926
-4% -$3.33K ﹤0.01% 3236
2023
Q4 		$69.6K Hold
44,614
– – ﹤0.01% 3363
2023
Q3 		$87.9K Buy
44,614
+7,976
+22% +$19.7K ﹤0.01% 3220
2023
Q2 		$117K Buy
+36,638
New +$115K ﹤0.01% 3205

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Deutsche Bank's CMPX Position: Q2 2026 in Review

Deutsche Bank increased its Compass Therapeutics (CMPX) stake by 0.75% in Q2 2026, buying an estimated $2.95K and bringing the position to 134,350 shares worth $294K. The position accounts for ﹤0.01% of the portfolio, ranked #3046.

Deutsche Bank first reported a position in CMPX in Q2 2023 and has held it in 12 quarters since. The position peaked at $705K in Q1 2026. 216 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Deutsche Bank held 134,350 shares of Compass Therapeutics worth $294K as of Q2 2026.
  • Deutsche Bank bought 998 Compass Therapeutics shares in Q2 2026, an estimated $2.95K.
  • Compass Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3046 holding.
  • Deutsche Bank first reported a position in Compass Therapeutics in Q2 2023 and has held it in 12 quarters since.
  • Deutsche Bank's Compass Therapeutics position peaked at $705K in Q1 2026.
  • 216 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.